Yongge Liu - Germantown MD, US Bing Sun - Gaithersburg MD, US Masuhiro Yoshitake - Potomac MD, US Jun-ichi Kambayashi - Potomac MD, US
International Classification:
A61K 31/4709 A61K 31/519 A61K 31/522 A61P 9/00
US Classification:
51426331, 514312, 5142621
Abstract:
The present invention relates to pharmaceutical compositions comprising at least one multifunctional phosphodiesterase inhibitor (MPDEI) and at least one adenosine uptake inhibitor. The present invention also relates to compositions comprising cilostazol and dipyridamole and their use.
Pharmaceutical Compositions Comprising A Multifunctional Phosphodiesterase Inhibitor And An Adenosine Uptake Inhibitor
Yongge LIU - Germantown MD, US Bing SUN - Gaithersburg MD, US Masuhiro YOSHITAKE - Potomac MD, US Jun-ichi KAMBAYASHI - Potomac MD, US
International Classification:
A61K 31/519 A61P 9/00
US Classification:
5142621
Abstract:
The present invention relates to pharmaceutical compositions comprising at least one multifunctional phosphodiesterase inhibitor (MPDEI) and at least one adenosine uptake inhibitor. The present invention also relates to compositions comprising cilostazol and dipyridamole and their use.
Pharmaceutical Compositions Comprising A Multifunctional Phosphodiesterase Inhibitor And An Adenosine Uptake Inhibitor
Yongge Liu - Germantown MD, US Bing Sun - Gaithersburg MD, US Masuhiro Yoshitake - Potomac MD, US Jun-ichi Kambayashi - Potomac MD, US
International Classification:
A61K031/519 A61K031/522 A61K031/4745
US Classification:
514262100, 514263320, 514301000
Abstract:
The present invention relates to pharmaceutical compositions comprising at least one multifunctional phosphodiesterase inhibitor (MPDEI) and at least one adenosine uptake inhibitor. The present invention also relates to compositions comprising cilostazol and dipyridamole and their use.